The main investor in a marijuana company licensed by the U.S. Drug Enforcement Administration (DEA) has contradicted reports of the company’s dissolution. Robert Kinsley, CEO of Kinsley Enterprises and the primary investor in Groff NA Hemplex, confirmed that the DEA-licensed cannabis cultivation enterprise is still operational and has recently renewed its agreement with the DEA. Kinsley stated that Groff NA is actively working with research partners and is in the final stages of securing institutional funding. Groff NA holds six DEA cannabis registrations and remains one of the DEA’s active partners in supporting cannabis researchers.
This clarification comes after reports from a former Groff NA Hemplex production manager, Robert Travers, who suggested that the company had lost funding and dissolved. The company’s status was also questioned following the death of its founder and chief medical officer, Dr. Stephen Groff, in June. Kinsley mentioned that they are in the process of adding new leadership to the team and continuing to focus on innovation in the cannabis sector.
Despite these doubts, Groff NA was still listed among the eight entities with DEA licenses to cultivate cannabis. The DEA recently announced plans to increase delta-9 THC production, and the agency is considering recommendations to reclassify marijuana as a Schedule 3 substance, a potential shift from its current Schedule 1 classification. The licenses granted in 2021 allowed specific entities, including Groff NA, to grow marijuana for research purposes.
, an independent military force, and allied militias in Sudan raped several dozen women and girls in West Darfur’s capital, El Geneina, and those fleeing to Chad between late April and late June 2023, Human Rights Watch said today. The assailants appear to have targeted people because of their Massalit ethnicity and, in some cases, because they were known activists.){kind=link}